Patients reveal willingness to trade hands-on medical care for computer con... ( BOSTON -- As President Barack Obama ...)

Patients reveal willingness to trade hands-on medical care for computer consultations

Date:5/18/2009

BOSTON -- As President Barack Obama calls for streamlining heath care by fully converting to electronic medical records and as Congress prepares to debate issues of patient privacy, one question has largely gone unasked: What do patients want?

A qualitative study led by a research team at Beth Israel Deaconess Medical Center (BIDMC) helps answer that question. Reported in the June 2009 issue of the Journal of General Internal Medicine (JGIM), the findings provide key insights into consumer preferences, suggesting that patients want full access to all of their medical records, are willing to make some privacy concessions in the interest of making their medical records completely transparent, and that, going forward, fully expect that computers will play a major role in their medical care, even substituting for face-to-face doctor visits.

"We set out to study patient attitudes toward electronic personal health records and other emerging and future electronic health information technologies," explains the study's lead author Jan Walker, RN, MBA, Instructor in Medicine in the Division of General Medicine and Primary Care at BIDMC and Harvard Medical School. "And we learned that, for the most part, patients are very comfortable with the idea of computers playing a central role in their care." In fact, she adds, patients said they not only want computers to bring them customized medical information, they fully expect that in the future they will be able to rely on electronic technology for many routine medical issues.

"Patients know how busy their doctors are and they want to reserve us for what they really need us for treating serious illness and conditions," adds senior author Tom Delbanco, MD, the Richard and Florence Koplow-James Tullis Professor of General Medicine and Primary Care at Harvard Medical School and BIDMC. "They may be more than happy to rely on computer protocols and 'faceless doctors' to help them manage garden-v
'/>"/>

Contact: Bonnie Prescott
bprescot@bidmc.harvard.edu
617-667-7306
Beth Israel Deaconess Medical Center
Source:Eurekalert

0

GOOD

Page: 1 2 3
Related medicine news :

1. Fluctuating eye pressure associated with visual field deterioration in glaucoma patients
2. Comparison of obstetric outcomes between on-call and patients own obstetricians
3. Vision restoration therapy shown to improve brain activity in brain injured patients
4. Diabetes appears to increase risk of death for patients with acute coronary syndromes
5. Ambulatory oxygen rarely a benefit in COPD patients without resting hypoxemia
6. Restricting Blood Flow May Help Heart Bypass Patients
7. Patients with Medicaid and those lacking insurance have higher risk of advanced laryngeal cancer
8. Study provides hope that some transplant patients could live free of antirejection drugs
9. Study provides hope that some transplant patients could live free of anti-rejection drugs
10. Longer ambulance journeys boost death risk for seriously ill patients
11. Expenses Overshadow Optimism for Kidney Failure Patients

Post Your Comments:

(Date:3/17/2010)... local union reformers and whistleblowers who exposed the union,s corruption and backroom deals and helped healthcare workers protect their democratic right to join a new union ... ... ... ... On Monday, SEIU ...

(Date:3/17/2010)... finds , , WEDNESDAY, March 17 (HealthDay News) -- Gays and ... sexual health such as impotence or low sex drive, a ... more prevalent than one might have guessed." said Roland Dunbrack, ... 18 issue of the New England Journal of Medicine ... in most cases, doesn,t need to be used," said Dunbrack, ...

(Date:3/17/2010)... The world’s largest HVAC/R exposition comes to Las Vegas for ... ... Vegas, NV (Vocus) March 17, 2010, , , , ,Calendar ... February 2 ,Las Vegas Convention Center ,Las Vegas, Nevada , ... Refrigerating Exposition) , ...

(Date:3/17/2010)... of Life Care , ... , , ... ... ... BOISE, Idaho , March 17 Idahoans may soon learn someone else,s "conscience" at the worst possible time. Today, after two days of ...

(Date:3/17/2010)... University of Texas M. D. Anderson Cancer Center ... with advanced or recurrent endometrial cancer, gemcitabine and ... rate in fifty percent of patients. , Jubilee ... Department of Gynecologic Oncology, presented the findings at ... Oncologists, 41st Annual Meeting on Women,s Cancer. , ...

Breaking Medicine News(10 mins):Health News:Democracy on Trial: SEIU's $25 Million Lawsuit Against Union Reformers Goes to Court Monday 2 Health News:Democracy on Trial: SEIU's $25 Million Lawsuit Against Union Reformers Goes to Court Monday 3 Health News:Gays, Lesbians Excluded From Some Medical Studies 2 Health News:2011 AHR EXPO Calendar Listing 2 Health News:2011 AHR EXPO Calendar Listing 3 Health News:2011 AHR EXPO Calendar Listing 4 Health News:Idaho Passes Bill to Put 'Conscience' Between Patients & End of Life Rights 2 Health News:Idaho Passes Bill to Put 'Conscience' Between Patients & End of Life Rights 3 Health News:Researchers find new chemotherapy combination shows promise in endometrial cancer 2

[0] Democracy on Trial: SEIU's $25 Million Lawsuit Against Union Reformers Goes to Court Monday [1] Gays, Lesbians Excluded From Some Medical Studies [0] 2011 AHR EXPO Calendar Listing [0] Idaho Passes Bill to Put 'Conscience' Between Patients & End of Life Rights [0] Researchers find new chemotherapy combination shows promise in endometrial cancer

... services has become an increasingly important issue with the ... ,Four separate articles in the latest ... related to the implementation of the program. ... Head of Colorectal Medicine and Genetics at Royal Melbourne ...

... father passed on a rare side effect of the smallpox vaccination ... , The boy who is currently being treated at University ... 80 percent of his body. ,Eczema vaccinatum is an ... who receive the shot or their close contacts. , ...

... a ray of hope to persons suffering from aniridia - a ... 1,000 people in the UK alone, suffer from this rare ... cells that can rejuvenate tissue in the eye. ,Sufferers ... or cataracts - when they are young. , Aniridia ...

... be gold, according to the journal Proceedings of the National ... vaccines are losing their efficiency in// preventing tuberculosis, and scientists ... , The scientists led by Dr. Roland Brosch ... or bacillus Calmette Guerin vaccines used in immunization ...

... the ill effects of second-hand tobacco smoke than their white ... with asthma. ,Black children who were exposed to ... levels in their hair and blood than white children with ... metabolize or break down nicotine more slowly than white children," ...

... is the first in the state to perform a ... stimulate regeneration of the heart muscle after a// heart ... centers in the country providing this new treatment modality ... Amorcyte, a privately funded cell-therapy company studying stem cells ...

Other Medicine News:Health News:Bowel Cancer Screening Program 2 Health News:Toddler Infected With Rare Side Effect of Smallpox Vaccine 2 Health News:TB Vaccines: Ring Out the New, Bring in the Old 2 Health News:Vanderbilt Performs State's First Stem Cell Heart Regeneration Therapy 2 Health News:Vanderbilt Performs State's First Stem Cell Heart Regeneration Therapy 3

Bowel Cancer Screening Program Toddler Infected With Rare Side Effect of Smallpox Vaccine Let Blind Eyes Be Opened - Stem Cell Therapy and Aniridia TB Vaccines: Ring Out the New, Bring in the Old Black Children More Vulnerable to Tobacco Smoke Effects Vanderbilt Performs State's First Stem Cell Heart Regeneration Therapy

(Date:3/17/2010)... , March 17 Zogenix, ... that it has initiated a pivotal Phase 3 ... formulation of hydrocodone without acetaminophen. ZX002 is being ... pain in individuals who require around-the-clock opioid therapy ... most widely prescribed drug in the United ...

(Date:3/17/2010)... Executives from pharmaceutical companies and health care payer and provider organizations ... discuss mutually beneficial partnerships that, if implemented, could replace the traditional model of ... on quantifying and communicating total value. , ... ... ...

(Date:3/17/2010)... Isis Pharmaceuticals, Inc. (Nasdaq: ISIS ), the leader in antisense therapeutics, today announced that management will present a company overview at Barclays, 2010 ... ... , , ... ... ...

[0] Zogenix Initiates Pivotal Phase 3 Clinical Trial for Novel Formulation of Oral Controlled-Release Hydrocodone [0] Drug Makers Discuss New Ways to Trim Health Care Costs at ZS Associates and eyeforpharma Forum [0] Isis Pharmaceuticals to Present at the Barclays Capital 2010 Global Healthcare Conference

... 12 Recent guidelines published by the,Clinical Resource ... use of bioimpedance technology for the early assessment ... titled "Guidelines for,the Diagnosis, Assessment and Management of ... patients and healthcare professionals that,reviewed the evidence for ...

... Md., June 12 ,Micromet, Inc. (Nasdaq: MITI ... has started treatment in a multi-center, phase 2 ... in,patients with adult acute lymphoblastic leukemia (ALL). Blinatumomab ... antigen, which is only expressed,on B cells. The ...

Other Medicine Technology:Published Guidelines Further Support Use of Bioimpedance Measurement Technology for Early Assessment of Lymphedema 2 Micromet and MedImmune Commence Treatment in Phase 2 Trial of BiTE Antibody Blinatumomab (MT103/MEDI-538) in Patients with Acute Lymphoblastic Leukemia 2 Micromet and MedImmune Commence Treatment in Phase 2 Trial of BiTE Antibody Blinatumomab (MT103/MEDI-538) in Patients with Acute Lymphoblastic Leukemia 3 Micromet and MedImmune Commence Treatment in Phase 2 Trial of BiTE Antibody Blinatumomab (MT103/MEDI-538) in Patients with Acute Lymphoblastic Leukemia 4 Micromet and MedImmune Commence Treatment in Phase 2 Trial of BiTE Antibody Blinatumomab (MT103/MEDI-538) in Patients with Acute Lymphoblastic Leukemia 5 Micromet and MedImmune Commence Treatment in Phase 2 Trial of BiTE Antibody Blinatumomab (MT103/MEDI-538) in Patients with Acute Lymphoblastic Leukemia 6

Published Guidelines Further Support Use of Bioimpedance Measurement Technology for Early Assessment of Lymphedema Micromet and MedImmune Commence Treatment in Phase 2 Trial of BiTE Antibody Blinatumomab (MT103/MEDI-538) in Patients with Acute Lymphoblastic Leukemia

...

The Doro Halo retractor system is designed for all neurosurgical applications where retraction of the brain tissue and an armrest is required....

Medicine Products:

Hudson-Downs Burr McKenzie Enlarging Burr Adson Perforating Burr Doro Halo Retractor System

Patients reveal willingness to trade hands-on medical care for computer con...( BOSTON -- As President Barack Obama ...),Health